Skip to main content
logo
InnoCan Pharma Corporation (INNPF)
OTCMKTS · Delayed Price · Currency is USD
4.710
0.00 (0.00%)
At close: Feb 11, 2026

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $6.82M in the quarter ending September 30, 2025, a decrease of -20.90%. This brings the company's revenue in the last twelve months to $27.03M, down -6.58% year-over-year. In the year 2024, InnoCan Pharma had annual revenue of $29.44M with 115.55% growth.

Revenue (ttm)
27.03M
Revenue Growth
-6.58%
P/S Ratio
0.93
Revenue / Employee
n/a
Employees
5
Market Cap
25.15M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202429.44M15.78M115.55%
Dec 31, 202313.66M11.10M433.69%
Dec 31, 20222.56M2.36M1,205.61%
Dec 31, 2021196.00K188.00K2,350.00%
Dec 31, 20208.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
The Stephan Co.15.66M
CCA Industries7.74M
DSwiss3.50M
PURE Bioscience2.35M
Adapti2.13M
Sentient Brands Holdings498.26K
Winning Brands407.23K
Kimberly Parry Organics187.70K
Revenue Rankings

InnoCan Pharma News

More News